These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15506480)

  • 1. [Effects of urotensin II on platelets].
    Shoji M; Yasujima M; Suda T
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():715-8. PubMed ID: 15506480
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation.
    Merten M; Beythien C; Gutensohn K; Kühnl P; Meinertz T; Thiagarajan P
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):258-63. PubMed ID: 15528476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Retention Index Test Homburg (RTH-II): Response to clopidogrel and comparison with aggregometry and CD62P-expression.
    Klinkhardt U; Wenzel E; Harder S
    Platelets; 2006 Feb; 17(1):42-8. PubMed ID: 16308186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin.
    Fox SC; May JA; Shah A; Neubert U; Heptinstall S
    Platelets; 2009 Jun; 20(4):250-9. PubMed ID: 19440925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Snake venom toxins affecting platelet function.
    Andrews RK; Gardiner EE; Berndt MC
    Methods Mol Biol; 2004; 273():335-48. PubMed ID: 15308810
    [No Abstract]   [Full Text] [Related]  

  • 6. [Urotensin II and cardiac disease].
    Nishikimi T
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():722-6. PubMed ID: 15506482
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet function assays.
    Rand ML; Leung R; Packham MA
    Transfus Apher Sci; 2003 Jun; 28(3):307-17. PubMed ID: 12725958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can hypertonic saline influence platelet P selectin expression and platelet-leukocyte aggregation?
    Huang GS; Hu MH; Lee CH; Tsai CS; Lin TC; Li CY
    Am J Emerg Med; 2010 Jan; 28(1):37-43. PubMed ID: 20006199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possible involvement of urotensin II in essential hypertension].
    Ikeda K; Tojo K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():727-9. PubMed ID: 15506483
    [No Abstract]   [Full Text] [Related]  

  • 10. [Overview of clinical applications of urotensin II].
    Imaki T; Tanabe A; Naruse M
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():730-4. PubMed ID: 15506484
    [No Abstract]   [Full Text] [Related]  

  • 11. Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates.
    Conlon JM; Yano K; Waugh D; Hazon N
    J Exp Zool; 1996 Jun 1-15; 275(2-3):226-38. PubMed ID: 8676097
    [No Abstract]   [Full Text] [Related]  

  • 12. Urotensin II in the cardiovascular system.
    Richards AM; Charles C
    Peptides; 2004 Oct; 25(10):1795-802. PubMed ID: 15476948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urotensin II: biological action on the kidney].
    Satoh F; Ito S
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():719-21. PubMed ID: 15506481
    [No Abstract]   [Full Text] [Related]  

  • 14. Iron-induced platelet aggregation measurement: a novel method to measure platelet function in stenting for ST segment elevation myocardial infarction.
    Smit JJ; van Oeveren W; Ottervanger JP; Slingerland RJ; Remijn JA; Zijlstra F; van 't Hof AW
    Eur J Clin Invest; 2009 Feb; 39(2):103-9. PubMed ID: 19200163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of therapeutic agents related to urotensin II].
    Mori M
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():741-4. PubMed ID: 15506486
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular role of urotensin II: effect of chronic infusion in the rat.
    Kompa AR; Thomas WG; See F; Tzanidis A; Hannan RD; Krum H
    Peptides; 2004 Oct; 25(10):1783-8. PubMed ID: 15476946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new highly sensitive method of analysis of thrombocyte aggregation].
    Gabbasov ZA; Popov EG; Gavrilov IIu; Pozin EIa; Markosian RA
    Lab Delo; 1989; (10):15-8. PubMed ID: 2481062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple platelet defects identified by flow cytometry at diagnosis in acute myeloid leukaemia.
    Leinoe EB; Hoffmann MH; Kjaersgaard E; Johnsen HE
    Br J Haematol; 2004 Oct; 127(1):76-84. PubMed ID: 15384980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point-of-care platelet function testing.
    Harle CC
    Semin Cardiothorac Vasc Anesth; 2007 Dec; 11(4):247-51. PubMed ID: 18270186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential sensitivity and kinetics of response of different ex vivo tests monitoring functional variability of platelet response to clopidogrel.
    Bal Dit Sollier C; Berge N; Boval B; Dubar M; Drouet L
    Thromb Haemost; 2010 Sep; 104(3):571-81. PubMed ID: 20664906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.